Psychological and cognitive outcomes in patients with unruptured intracranial aneurysms and aneurysmal subarachnoid haemorrhage: a multidimensional assessment

未破裂颅内动脉瘤和动脉瘤性蛛网膜下腔出血患者的心理和认知结局:一项多维度评估

阅读:1

Abstract

INTRODUCTION: Unruptured intracranial aneurysms (UIAs) and aneurysmal subarachnoid hemorrhage (aSAH) pose not only neurological but also psychological and cognitive challenges. This study aimed to compare patients with UIA and aSAH and explore how psychological symptoms relate to their quality of life (QoL). METHODS: Between May 2023 and May 2025, 128 patients (aged 31-79, M = 53.9, SD = 7.24) were enrolled: 63 with aSAH and 65 with UIA. All aSAH patients had favourable neurological outcomes (modified Rankin Scale score of 0 or 1). Assessment included the Montreal Cognitive Assessment (MoCA), State-Trait Anxiety Inventory - Trait (STAI-T), Beck Depression Inventory - Short Form (BDI-SF), Athens Insomnia Scale (AIS), Toronto Alexithymia Scale (TAS-20), and WHOQOL-BREF. RESULTS: There were no significant psychological or cognitive differences between the aSAH and UIA groups; thus, they were analysed together. Compared to normative data, patients showed reduced cognitive performance and elevated depressive symptoms. Psychological well-being was the most affected QoL domain. All psychological variables negatively correlated with QoL, with anxiety, depression, and sleep disturbances emerging as significant predictors in linear regression. DISCUSSION: Our results suggest that emotional and sleep-related symptoms have a more substantial impact on QoL than cognitive impairment. The lack of group differences implies that psychological vulnerability may already be present before aneurysm rupture, underlining the need for early intervention. CONCLUSION: The knowledge of having an aneurysm alone places a significant psychological burden on patients even without SAH, affecting cognitive and psychological well-being and quality of life. Therefore, psychological follow-up and care of patients diagnosed with intracranial aneurysms should be a priority. TRIAL REGISTRATION: Not applicable because the health-related intervention was not conducted in this study.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。